MEK inhibitor breakthroughs in Noonan syndrome — the targeted MAPK pathway therapies demonstrating cardiac function improvement in children with severe hypertrophic cardiomyopathy, alongside Novo...
Connexin 43 targeted therapy for oculodentodigital dysplasia — the precision medicine approach addressing the underlying GJA1 mutation disrupting gap junction intercellular communication, represe...
